We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Hospital Infections Prevalent in the United States

By HospiMedica staff writers
Posted on 09 Jul 2007
A new study reports that as many as 1.2 million hospital patients in the United States are infected with methicillin-resistant Staphylococcus aureus (MRSA) infections annually, with up to 120,000 patients of them dying.

The study, authored by Dr. More...
William Jarvis, former acting director of the hospital infections program at the Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) and currently at the Association for Professionals in Infection Control & Epidemiology (APIC, Washington, DC, USA), is based on surveys sent during 2006 to 10,000 infection-control practitioners, including doctors and nurses in hospitals, nursing homes, and rehabilitation facilities. Participants were asked to select one day between October 1, 2005, and November 10, 2005, and report all known MRSA cases in their institutions. More than 1,200 hospitals and 100 nursing homes and rehabilitation facilities responded, supplying data about patients with MRSA infections.

The findings showed that 34 of 1,000 patients in the survey had active MRSA infections and that 12 were colonized with the bacteria, for a total MRSA prevalence rate of 46 per 1,000 patients. Applying the prevalence rates in the new study, the data suggest that 1.2 million hospital patients are afflicted with MRSA each year and that an additional 423,000 patients are colonized with the superbacteria.

"Everything we're finding is telling us the same thing: MRSA is an enormous problem in health-care facilities, more needs to be done to prevent it, and hospitals need to make infection control more of a priority,” said Dr. John Jernigan, a medical epidemiologist at the CDC, and the agency's lead expert on MRSA.

People colonized with MRSA typically carry it in their nose without being symptomatic. The major risk of passing the super-bacteria to others unknowingly by wiping their nose and then touching a table that a doctor or nurse later touches, since MRSA can live on surfaces for days or even weeks.


Related Links:
Centers for Disease Control and Prevention
Association for Professionals in Infection Control & Epidemiology

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Electrode Solution and Skin Prep
Signaspray
Infrared Digital Thermometer
R1B1
Portable Jaundice Management Device
Nymphaea
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.